Endocrine Journal | |
Elevated Plasma Immunoreactive Neuropeptide Y Concentrations and Its Increased Urinary Excretion in Patients with Advanced Diabetic Nephropathy | |
CHIHARU SATOH6  MOTOJI FUKUDA6  KAZUHITO TOTSUNE6  MAKOTO OHNEDA6  SUSUMU OGAWA6  TORAICHI MOURI2  TOKUTARO SATO5  FUMITOSHI SATOH6  HIROTAKA NAGAKUBO6  KAZUHIKO SUGIMURA6  OSAMU MURAKAMI6  KAZUHIRO TAKAHASHI3  MASAHIKO SONE4  TAMAMI YABE1  | |
[1] Iwadeyama Hospital;Division of Neuroendocrinology, Mouri Clinic;Department of Molecular Biology and Applied Physiology, Tohoku University School of Medicine;Department of Medicine, National Iwate Hospital;the Rehabilitation Medicine, Tohoku University School of Medicine;Second Department of Internal Medicine, Tohoku University School of Medicine | |
关键词: Neuropeptide Y; Diabetes; Diabetic Nephropathy; Urine; | |
DOI : 10.1507/endocrj.46.139 | |
学科分类:内分泌与代谢学 | |
来源: Japan Endocrine Society | |
【 摘 要 】
References(38)Cited-By(13)Neuropeptide Y (NPY) is a potent vasoconstrictor peptide that is abundant in the brain and the peripheral sympathetic nervous system. In the present study we investigated possible changes in plasma immunoreactive (IR)-NPY concentrations and urinary IR-NPY excretion in patients with non-insulin dependent diabetes mellitus (NIDDM) and the relationship to diabetic complications, such as nephropathy and neuropathy. IR-NPY in plasma and urine was measured by radioimmunoassay in 69 patients with NIDDM. Plasma IR-NPY concentrations in patients with advanced nephropathy (creatinine clearance <30ml/min) (100.5±10.3pmol/l, n=9, mean±SEM) were higher than in the control subjects (55.0±6.8 pmol/l, n=15) (P<0.02). Urinary excretion of IR-NPY and fractional excretion of NPY were also increased in the patients with advanced nephropathy. Sephadex G-50 column chromatography of the urine extracts obtained from healthy subjects, diabetic patients with renal failure and non-diabetic patients with renal failure showed an immunoreactive peak eluting in the NPY position. On the other hand, neither plasma nor urinary IR-NPY was high in patients with retinopathy, or in patients with peripheral neuropathy. The present study has, for the first time, shown high plasma IR-NPY concentrations and urinary IR-NPY excretion in NIDDM patients with advanced nephropathy.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201911300217525ZK.pdf | 1172KB | download |